RxDoctor Payments DataLook up a doctor →

Nulibry: payments to doctors

Payments that named Nulibry as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$716K
Providers
13
Transactions
67
Average per transaction
$10,691

The per-transaction average — $10,691 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13 providers the average total is $55,101, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Sentynl Therapeutics, Inc.$716,311100.0%
← All drugs & devices